cGMP

Sterling Pharma Solutions and Kivu Bioscience Enter Manufacturing Pact

Sterling Pharma Solutions to produce an antibody-drug conjugate (ADC) candidate for Kivu Bioscience.

Cambrex Opens New Stability Storage Facility

Today, Cambrex announced its stability storage business, Q1 Scientific, and opened a new cGMP facility in Durham, North Carolina, expanding its capacity for environmentally controlled stability storage services to North America's pharmaceutical, medical device, and life sciences industries.

Serán More Than Doubles Clinical Manufacturing Capacity

CDMO Serán BioScience recently announced that it has completed an expansion to increase the number of process manufacturing suites at its facility in Bend, Oregon, from 6 to 14, adding approximately 130% more cGMP clinical manufacturing capacity.

Catalent Opens Cell Therapy Facility in Belgium

Catalent has opened a new commercial-scale cell therapy manufacturing facility at its European center of excellence for cell therapies in Gosselies, Belgium.

Cambrex Takes Snapdragon Chemistry

US CDMO Cambrex has agreed to buy Snapdragon Chemistry, a compatriot company specializing in developing continuous flow and batch processes for APIs. Snapdragon is based in Waltham, Massachusetts, where it employs 74 people.

Change of Ownership for US CDMO Alcami

UK specialist healthcare investor GHO Capital Partners and US investment firm The Vistria Group have entered into an agreement to buy a controlling interest in US CDMO Alcami from current private equity owners Madison Dearborn Partners (MDP) and Ampersand Capital Partners. Financial terms of the deal were not disclosed.

Ariceum and AmbioPharm in Peptide Partnership

Ariceum Therapeutics, a Berlin-headquartered private biotech developing radiopharmaceutical products for the diagnosis and systemic targeted certain hard-to-treat cancers, and AmbioPharm, a globally oriented US CDMO specialized in peptides, have agreed a strategic partnership in peptide conjugates.

Recipharm Bolsters Blow-Fill-Seal Capabilities in France

Swedish multinational CDMO Recipharm has bolstered its sterile filling capabilities at its facility in Kaysersberg, France, by installing Lab+ continuous automated technology.

Catalent to Invest $12 Million at Kansas City

Catalent has announced a $12 million expansion program to increase biologics CGMP analytical capabilities at its flagship facility in Kansas City, Missouri.

Evotec Enhances Rare Disease Focus with Central Glass Buy

German CDMO Evotec is to acquire compatriot company Central Glass Germany from Japanese owner Central Glass for a nominal price of €1. The transaction, which remains subject to the usual closing conditions, is expected to complete on Nov. 1.

Cambrex to Upgrade Generic API Manufacturing Facilities at Milan Site

Supply Security of Non-cGMP Materials

PMC Buys Isochem’s Pharma Business

Lonza Buys Shire US Site

Cambrex Invests in Swedish cGMP Facility

Umicore Facility in Argentinia Passes new European cGMP Audit

Cambrex Validates Milan API Pilot Plant

Particle Sciences Adds Filling Capacity

Millipore Sigma Expands cGMP Capacity

Dishman: Successful FDA Inspection at Dutch Site

SGS Life Science Services Doubles Mumbai Plant Size

Opportunities Through Biotechnology

Good Manufacturing Practices

Evolution of a Dynamic Healthcare Market

Essential Ingredients

A Shaky Platform?

United in Philosophy and Approach

Value Over Price

Saltigo to Actively Develop Attractive Lines of Business

Vetter's Newest Facility Successfully Completes FDA Inspection

Product Protection by Implementation of Improved Hygiene Zones

Fujifilm Diosynth Biotechnologies Expands Mammalian Cell Culture cGMP Capabilities

Novozymes Now Supplying Pharmaceutical Grade Q7 cGMP Hyaluronic Acid

How Solvias Relocated to a New Location without Missing a Beat

Time For Action